Citation

BibTex format

@article{Canonica:2014:10.1186/1939-4551-7-6,
author = {Canonica, GW and Cox, L and Pawankar, R and Baena-Cagnani, CE and Blaiss, M and Bonini, S and Bousquet, J and Calderón, M and Compalati, E and Durham, SR and van, Wijk RG and Larenas-Linnemann, D and Nelson, H and Passalacqua, G and Pfaar, O and Rosário, N and Ryan, D and Rosenwasser, L and Schmid-Grendelmeier, P and Senna, G and Valovirta, E and Van, Bever H and Vichyanond, P and Wahn, U and Yusuf, O},
doi = {10.1186/1939-4551-7-6},
journal = {World Allergy Organ J},
title = {Sublingual immunotherapy: World Allergy Organization position paper 2013 update.},
url = {http://dx.doi.org/10.1186/1939-4551-7-6},
volume = {7},
year = {2014}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - We have prepared this document, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update", according to the evidence-based criteria, revising and updating chapters of the originally published paper, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2009", available at http://www.waojournal.org. Namely, these comprise: "Mechanisms of sublingual immunotherapy;" "Clinical efficacy of sublingual immunotherapy" - reporting all the data of all controlled trials published after 2009; "Safety of sublingual immunotherapy" - with the recently published Grading System for adverse reactions; "Impact of sublingual immunotherapy on the natural history of respiratory allergy" - with the relevant evidences published since 2009; "Efficacy of SLIT in children" - with detailed analysis of all the studies; "Definition of SLIT patient selection" - reporting the criteria for eligibility to sublingual immunotherapy; "The future of immunotherapy in the community care setting"; "Methodology of clinical trials according to the current scientific and regulatory standards"; and "Guideline development: from evidence-based medicine to patients' views" - including the evolution of the methods to make clinical recommendations.Additionally, we have added new chapters to cover a few emerging crucial topics: "Practical aspects of schedules and dosages and counseling for adherence" - which is crucial in clinical practice for all treatments; "Perspectives and new approaches" - including recombinant allergens, adjuvants, modified allergens, and the concept of validity of the single products. Furthermore, "Raising public awareness about sublingual immunotherapy", as a need for our patients, and strategies to increase awareness of allergen immunotherapy (AIT) among patients, the medical community, all healthcare stakeholders
AU  - Canonica,GW
AU  - Cox,L
AU  - Pawankar,R
AU  - Baena-Cagnani,CE
AU  - Blaiss,M
AU  - Bonini,S
AU  - Bousquet,J
AU  - Calderón,M
AU  - Compalati,E
AU  - Durham,SR
AU  - van,Wijk RG
AU  - Larenas-Linnemann,D
AU  - Nelson,H
AU  - Passalacqua,G
AU  - Pfaar,O
AU  - Rosário,N
AU  - Ryan,D
AU  - Rosenwasser,L
AU  - Schmid-Grendelmeier,P
AU  - Senna,G
AU  - Valovirta,E
AU  - Van,Bever H
AU  - Vichyanond,P
AU  - Wahn,U
AU  - Yusuf,O
DO  - 10.1186/1939-4551-7-6
PY  - 2014///
SN  - 1939-4551
TI  - Sublingual immunotherapy: World Allergy Organization position paper 2013 update.
T2  - World Allergy Organ J
UR  - http://dx.doi.org/10.1186/1939-4551-7-6
UR  - https://www.ncbi.nlm.nih.gov/pubmed/24679069
VL  - 7
ER  -
Download